Anna Rozenfeld Hemed

WED-500 Post trans-jugular intrahepatic portosystemic shunt development of hepatic encephalopathy is not changed by early prophylactic treatment and does not increase mortality

Anna Rozenfeld Hemed, Niv Zmora, Oren Shibolet, Liane Rabinowich

The predictive value of coronary artery calcium deposit for cardiovascular events in patients treated with immune checkpoint inhibitors

Moaad Slieman, Ophir Freund, Galit Aviram, Haim Shmilovich et autres

BACKGROUND: Immune checkpoint inhibitors (ICIs) have become the standard for treating various cancers. Nevertheless, their use may lead to significant cardiovascular immune-related adverse events (CV irAEs). OBJECTIVES: We aimed to assess whether pre-treatment coronary artery calcium (CAC) deposition predicts CV irAEs in …

il, us (code pays fourni par la source)

Real-Life Management of Elevated Troponin Level in Patients Treated with Immune Checkpoint Inhibitors

Lior Zornitzki, Dana Viskin, Ophir Freund, Ido Wolf et autres

Background: Immune checkpoint inhibitors (ICIs) have revolutionized the clinical outcomes of cancer. Nevertheless, their use may lead to myocardial injury. The 2022 European Society of Cardiology cardio-oncology guidelines recommend routine follow-up of troponin level; however, current guidelines do not provide specific protocols …

il (code pays fourni par la source)

Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function

Maor Tzuberi, Rafael Y. Brzezinski, Nir Flint, Moaad Slieman et autres

AIMS: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment outcomes. However, the response varies across different populations, and their use may lead to life-threatening cardiovascular (CV) events. While pre-treatment reduced left ventricular ejection fraction (LVEF) is considered a marker for high-risk cardiotoxicity …

il, nl (code pays fourni par la source)

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Pre-treatment Reduced Left Ventricular Function

Maor Tzuberi, Rafael Y. Brzezinski, Nir Flint, Moaad Slieman et autres

il (code pays fourni par la source)

Tu1835 COMPARATIVE EFFECTIVENESS AND SAFETY OF INFLIXIMAB AND TACROLIMUS IN THE TREATMENT OF ACUTE SEVERE ULCERATIVE COLITIS

Nathaniel A. Cohen, Natalie Tamir‐Degabli, Anna Rozenfeld Hemed, Ayal Hirsch et autres

P796 Comparative Effectiveness of First-Line Infliximab and Vedolizumab in Patients with Early Ulcerative Colitis

Anna Rozenfeld Hemed, Nathaniel A. Cohen, O Green, Ayal Hirsch et autres

Abstract Background Despite the increasing armamentarium of advanced therapies for the treatment of ulcerative colitis (UC), data comparing the effectiveness of biologics in early disease are scarce. We aimed to categorize selection of patients and assess the effectiveness, therapeutic persistence and safety …

il (code pays fourni par la source)